ArticleOrphanet journal of rare diseases2026
Health service access and delivery for people living with rare disorders: a scoping review.
Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRare disorders contribute significant collective health system costs; individuals living with rare disorders frequently encounter diagnostic, treatment, and management barriers. Despite international recognition of these challenges, there remains limited research addressing systemic health service delivery and access barriers for those with rare disorders, or identification of how such research informs policymaking.
methodsDimensions, PubMed, Scopus, ProQuest, CINAHL, and Ovid platform databases were employed in a search of qualitative research documenting the health service experiences of people living with rare disorders and their primary support networks. A total of 4,615 records were identified and after de-duplication, screened by title, keywords, and abstract. Seventy-eight publications met the inclusion criteria after full text screening, these were then reviewed. Policy impact in the form of citations was determined by whether an Overton search identified a link between the reviewed studies and policy documents.
resultsTwo primary findings were identified. (1) Health service access and delivery barriers are pervasive. People living with rare disorders and their support networks manage emotional, financial, and social challenges. There is an urgent need for improved service delivery, including better access, education, psychological, and peer support. (2) Reviewed studies, covering only a small subset of identified rare disorders, are published largely in specialised rare disorders journals and often failed to adopt inclusive methods. Few included publications were cited in policy-related documents retrieved through Overton, and several identified citations were incidental rather than substantive.
interpretationDespite growing awareness, health systems fall short of addressing structural barriers faced by people living with rare disorders. The findings support development of a global coordinated action plan for rare disorder management and its subsequent implementation following adoption. For researchers, this could include adoption of inclusive research methods. For policymakers, there is a need for stronger inclusion of equity-priority populations and coordinated policy frameworks that recognise the collective impact of disparate and poorly managed care. Critical to supporting change is investment in the upskilling of the health workforce and clinicians' active engagement in diagnosis, coordination, long-term management, and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.